Immunate S/D 250 I.E.

Immunate S/D 250 I.E. is a medicine authorised by Swissmedic under authorisation number 52715. The authorisation holder is Takeda Pharma AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 August 1995 and the authorisation is valid without a time limit. ATC code B02BD06 places the medicine in the group Antihemorrhagics.

  • Dispensing category B
  • Authorisation number 52715
  • ATC B02BD06
  • Blood products
Authorisation data
Authorisation number52715
NameImmunate S/D 250 I.E.
Full nameImmunate S/D 250 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Authorisation holderTakeda Pharma AG
Medicinal product codeBlood products
Dispensing categoryB · Prescription only
ATC codeB02BD06
First authorisation24 August 1995
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
4Immunate S/D 250 I.E., Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB01 January 2005
5Immunate S/D 500 I.E., Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB01 January 2005
6Immunate S/D 1'000 I.E., Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB01 January 2005

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
16250I.E.B02BD0606.01.1.B
24500I.E.B02BD0606.01.1.B
321000I.E.B02BD0606.01.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Immunate S/D 250 I.E. authorised in Switzerland?

Yes. Immunate S/D 250 I.E. is authorised by Swissmedic under authorisation number 52715, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Immunate S/D 250 I.E. have?

Immunate S/D 250 I.E. is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Immunate S/D 250 I.E.?

The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com